Table 5 Tumour-to-liver (SUVmax/SUVmean), by peptide mass and radioactivity range
Peptide mass range | Radioactivity range | |||||
|---|---|---|---|---|---|---|
Organ | Statistic | 5–20 µg (N = 24) | 30–45 µg (N = 24) | 40–80 MBq (N = 16) | 100–140 MBq (N = 16) | 160–200 MBq (N = 16) |
Primary tumour site | n | 6 | 5 | 3 | 5 | 3 |
Mean ± SD | 32.1 ± 39.22 | 29.2 ± 28.01 | 41.4 ± 53.08 | 30.1 ± 27.67 | 21.3 ± 27.78 | |
Median (range) | 12.6 (4.94–102.40) | 16.5 (5.57–64.98) | 16.2 (5.67–102.40) | 16.5 (5.31–64.98) | 5.6 (4.94–53.36) | |
Liver | n | 18 | 18 | 13 | 10 | 13 |
Mean ± SD | 11.5 ± 10.51 | 13.6 ± 11.72 | 12.9 ± 9.94 | 13.0 ± 11.87 | 11.8 ± 12.20 | |
Median (range) | 8.6 (3.28–40.14) | 8.4 (5.08–48.79) | 9.9 (5.60–37.00) | 7.7 (4.85–40.14) | 7.0 (3.28–48.79) | |
Lymph nodes | n | 14 | 14 | 8 | 9 | 11 |
Mean ± SD | 13.2 ± 8.52 | 13.1 ± 8.98 | 13.8 ± 9.78 | 13.7 ± 8.93 | 12.3 ± 8.18 | |
Median (range) | 10.1 (4.42–27.43) | 8.6 (2.26–28.98) | 8.6 (5.56–28.98) | 10.8 (4.42–26.46) | 9.8 (2.26–25.14) | |